Lv3
208 积分 2025-09-24 加入
IP16-26 EPB41L2 SUPPRESSES MALIGNANT PROGRESSION OF CLEAR CELL RENAL CELL CARCINOMA AND INHIBITS M2 POLARIZATION OF TUMOR-ASSOCIATED MACROPHAGES VIA MAPK SIGNALING PATHWAY: INSIGHTS FROM BULK SEQUENCING, SINGLE-CELL AND SPATIAL TRANSCRIPTOMIC SEQUENCING
17天前
已完结
IP16-26 EPB41L2 SUPPRESSES MALIGNANT PROGRESSION OF CLEAR CELL RENAL CELL CARCINOMA AND INHIBITS M2 POLARIZATION OF TUMOR-ASSOCIATED MACROPHAGES VIA MAPK SIGNALING PATHWAY: INSIGHTS FROM BULK SEQUENCING, SINGLE-CELL AND SPATIAL TRANSCRIPTOMIC SEQUENCING
17天前
已关闭
Serum FGF21 levels are increased in newlydiagnosed type 2 diabetes with nonalcoholicfatty liver disease and associated with hsCRPlevels independently
2个月前
已关闭
Insight to the association among fibroblastgrowth factor 21, non-alcoholic fatty liverdisease and cardiovascular outcomes: Apopulation-based study
2个月前
已关闭
FAM83A acts as an amplifier for lipogenic signalingto facilitate the pathogenesis of metabolicdysfunction-associated steatohepatitis
2个月前
已关闭
Macrophages Atp6vod2 regulates XBP1-mediatedcholesterol metabolism to suppress metabolicdysfunction-associated steatohepatitis progression
2个月前
已完结
What Is Metabolic Dysfunction–Associated Steatotic Liver Disease?
2个月前
已关闭
Why timing matters in MASLD: Late-day metabolic control
2个月前
已完结
Multimodal biomedical Al
2个月前
已完结
Association of Metabolic Dysfunction–Associated Steatotic Liver Disease With Features of Cerebral Small‐Vessel Disease on Magnetic Resonance Images: A Large Cross‐Sectional Study
2个月前
已完结
皖公网安备34019202002308
